Home >> Chemicals Listing >> hot product list by 1  

19-Norpregn-5(10)-en-20-yn-3-one,17-hydroxy-7-methyl-, (7a,17a)- (5630-53-5)

Identification
Name:19-Norpregn-5(10)-en-20-yn-3-one,17-hydroxy-7-methyl-, (7a,17a)-
Synonyms:19-Nor-17a-pregn-5(10)-en-20-yn-3-one, 17-hydroxy-7a-methyl- (7CI,8CI);(7a,17a)-17-Hydroxy-7-methyl-19-norpregn-5(10)-en-20-yn-3-one;7a-Methyl-17a-ethynyl-17b-hydroxy-5(10)-estren-3-one;7a-Methyl-D5,10-norethindrone;Livial;Liviella;Org OD 14;
CAS:5630-53-5
EINECS: 227-069-1
Molecular Formula: C21H28O2
Molecular Weight: 312.44582
InChI: InChI=1S/C21H28O2/c1-4-21(23)10-8-18-19-13(2)11-14-12-15(22)5-6-16(14)17(19)7-9-20(18,21)3/h1,13,17-19,23H,5-12H2,2-3H3/t13-,17-,18+,19-,20+,21+/m1/s1
Molecular Structure: (C21H28O2) 19-Nor-17a-pregn-5(10)-en-20-yn-3-one, 17-hydroxy-7a-methyl- (7CI,8CI);(7a,17a)-17-Hydroxy-7-methyl-...
Properties
Transport:HAZARD
Melting Point: 163 - 169 C
Density:1.13g/cm3
Water Solubility:practically insoluble (soluble in chloroform, methanol)
Solubility:practically insoluble (soluble in chloroform, methanol)
Appearance:white to off-white crystalline powder
Specification:
White Solid
usageEng:A synthetic steroid with weak estrogenic, androgenic and progestogenic activity. A pharamceutical used in the treatment of menopausal syndrome
Safety Statements:22-24/25-61
22:Do not breathe dust
24/25:Avoid contact with skin and eyes
61:Avoid release to the environment. Refer to special instructions safety data sheet
Usage:

A synthetic steroid with weak estrogenic, androgenic and progestogenic activity. A pharamceutical used in the treatment of menopausal syndrome

Safety Data